J.J. McCarthy woke up the morning of Aug. 11, walked down the stairs at his house and his knee buckled. The feeling of instability in his knee was something he hadn’t ever experienced before.

While many kinds of smart TVs offer a convenient 'ESPN Plus' button to open the app, Vizio TVs don't; that doesn't mean you can't use the popular sports streaming service though, and we'll help you ...

IRVINE, Calif.—In a sign of how important advertising has become to makers of TV sets, Vizio has announced that its popular WatchFree+ service is now available on the Vizio mobile app for iOS and ...

A Vizio remote may stop working due to power drained device batteries, blocked TV sensors, power residue from remote and TV, dirty power source, stuck memory on the remote and even issues with the TV ...

That being said, we actually came across a solid deal on a small TV from Target: For a limited time, you can purchase the Vizio 24-inch D-Series 1080p Smart TV for $130. At full price, this set is ...

On Ravenite Social Club, Juicy J employs the talents of jazz musicians like Robert Glasper and Emi Secrest. He produces everything himself, chopping up expansive horns and keys into beats that ...

Johnson & Johnson is opening a new front in the pharmaceutical industry’s fight against lucrative drug discounts for hospitals. Johnson & Johnson told certain hospitals around the U.S. Friday ...

The unfortunate season-ending injury to J.J. McCarthy temporarily puts the Minnesota Vikings' young franchise quarterback on the shelf until 2025, but the development plan should not change for ...

J&J has announced plans to finalize a $6.48 billion global settlement through the bankruptcy of a subsidiary company, after earlier efforts were rebuffed twice by federal courts. J&J says the ...

Johnson & Johnson JNJ said Tuesday it has agreed to acquire V-Wave Ltd., a privately held company developing treatments for patients with heart failure, for $600 million upfront and potential ...

The approval allows the use of the cancer drug, Rybrevant, in combination with J&J's existing drug, lazertinib, as a first-line treatment for non-small cell lung cancer (NSCLC) patients with a ...